The Role of Microglia in Brain Metastases: Mechanisms and Strategies
Authors:
Open Access
- 1 January 2024
- journal article
- review article
- Published by Aging and Disease in Aging and disease
- Vol. 15 (1) , 169-185
Abstract
Brain metastases and related complications are one of the major fatal factors in cancer. Patients with breast cancer, lung cancer, and melanoma are at a high risk of developing brain metastases. However, the mechanisms underlying the brain metastatic cascade remain poorly understood. Microglia, one of the major resident macrophages in the brain parenchyma, are involved in multiple processes associated with brain metastasis, including inflammation, angiogenesis, and immune modulation. They also closely interact with metastatic cancer cells, astrocytes, and other immune cells. Current therapeutic approaches against metastatic brain cancers, including small-molecule drugs, antibody-coupled drugs (ADCs), and immune-checkpoint inhibitors (ICIs), have compromised efficacy owing to the impermeability of the blood-brain barrier (BBB) and complex brain microenvironment. Targeting microglia is one of the strategies for treating metastatic brain cancer. In this review, we summarize the multifaceted roles of microglia in brain metastases and highlight them as potential targets for future therapeutic interventions.Keywords
This publication has 151 references indexed in Scilit:
- MicroRNA and Protein Profiling of Brain Metastasis Competent Cell-Derived ExosomesPLOS ONE, 2013
- Neurotrophin-3 modulates breast cancer cells and the microenvironment to promote the growth of breast cancer brain metastasisOncogene, 2012
- Split Immunity: Immune Inhibition of Rat Gliomas by Subcutaneous Exposure to Unmodified Live Tumor CellsThe Journal of Immunology, 2011
- Treatment of Brain Inflammatory Diseases by Delivering Exosome Encapsulated Anti-inflammatory Drugs From the Nasal Region to the BrainMolecular Therapy, 2011
- Non-small Cell Lung Cancer Induces an Immunosuppressive Phenotype of Dendritic Cells in Tumor Microenvironment by Upregulating B7-H3Journal of Thoracic Oncology, 2011
- LKB1 inhibits lung cancer progression through lysyl oxidase and extracellular matrix remodelingProceedings of the National Academy of Sciences, 2010
- Improved Survival with Ipilimumab in Patients with Metastatic MelanomaNew England Journal of Medicine, 2010
- Chemokine (C-C Motif) Ligand 2 Engages CCR2+ Stromal Cells of Monocytic Origin to Promote Breast Cancer Metastasis to Lung and BoneJournal of Biological Chemistry, 2009
- Genes that mediate breast cancer metastasis to the brainNature, 2009
- Hepatocyte Growth Factor Specifically Expressed in Microglia Activated RAS in the Neurons, Similar to the Action of Neurotrophic FactorsBiochemical and Biophysical Research Communications, 1995